Karuna Therapeutics Stock Price Chart

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KRTX is experiencing buying pressure, which is a positive indicator for future bullish movement.

Karuna Therapeutics Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 189.57 Buy
20-day SMA: 180.87 Buy
50-day SMA: 174.08 Buy
200-day SMA: 193.23 Buy
8-day EMA: 188.81 Buy
20-day EMA: 182.57 Buy
50-day EMA: 178.99 Buy
200-day EMA: 187.44 Buy

Karuna Therapeutics Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): 5.32 Buy
Relative Strength Index (14 RSI): 64.89 Buy
Chaikin Money Flow: 192924 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (168.55 - 187.63) Buy
Bollinger Bands (100): (168.29 - 192.71) Buy

Karuna Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for Karuna Therapeutics Stock

Is Karuna Therapeutics Stock a Buy?

KRTX Technical Analysis vs Fundamental Analysis

Karuna Therapeutics (KRTX) is a Buy

Is Karuna Therapeutics a Buy or a Sell?

Karuna Therapeutics Stock Info

Market Cap:
Price in USD:
Share Volume:

Karuna Therapeutics 52-Week Range

52-Week High:
52-Week Low:
Karuna Therapeutics (KRTX) is a Buy

Karuna Therapeutics Share Price Forecast

Is Karuna Therapeutics Stock a Buy?

  • Karuna Therapeutics share price is 196.51 while KRTX 8-day exponential moving average is 188.81, which is a Buy signal.
  • The stock price of KRTX is 196.51 while Karuna Therapeutics 20-day EMA is 182.57, which makes it a Buy.
  • Karuna Therapeutics 50-day exponential moving average is 178.99 while KRTX share price is 196.51, making it a Buy technically.
  • KRTX stock price is 196.51 and Karuna Therapeutics 200-day simple moving average is 187.44, creating a Buy signal.

Fundamental Analysis of Karuna Therapeutics

Is Karuna Therapeutics a good investment?

  • Analysts estimate an earnings decrease this quarter of $0.43 per share, a decrease next quarter of $0.00 per share, a decrease this year of $2.18 per share, and an increase next year of $0.12 per share.

Technical Analysis of Karuna Therapeutics

Should I short Karuna Therapeutics stock?

* Karuna Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.